- Publications
- Search
- Statistics
Ovarian Cancer Pathology Characteristics as Predictors of Variant Pathogenicity in Brca1 and Brca2
AuthID
P-00Y-9WT
P-00Y-9WT
99
Author(s)
O’Mahony, DG
·Ramus, SJ
·Southey, MC
·Meagher, NS
·Hadjisavvas, A
·John, EM
·Hamann, U
·Imyanitov, EN
·Andrulis, IL
·Sharma, P
·[+79]·
Michailidou, K
·la Hoya, M
·van Overeem Hansen, T
·dos Santos, ES
·HEBON Investigators
·GEMO Study Collaborators
·AOCS Group
·CZECANCA Consortium
·The Consortium of Investigators of Modifiers of BRCA1/2
·Evidence based Network for the Interpretation of Germline Mutant Alleles Consortium
Document Type
Article
Year published
2023
Published
in British Journal of Cancer, ISSN: 0007-0920
Volume: 128, Issue: 12, Pages: 2283-2294
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0007-0920
Export Publication Metadata
Publication Export Settings
Marked List
Info
At this moment we don't have any links to full text documens.
| Name Order | Name | Name Order | Name | Name Order | Name | ||
|---|---|---|---|---|---|---|---|
| 1 | O’Mahony, DG; | 2 | Ramus, SJ; | 3 | Southey, MC; | ||
| 4 | Meagher, NS; | 5 | Hadjisavvas, A; | 6 | John, EM; | ||
| 7 | Hamann, U; | 8 | Imyanitov, EN; | 9 | Andrulis, IL; | ||
| 10 | Sharma, P; | 11 | Daly, MB; | 12 | Hake, CR; | ||
| 13 | Weitzel, JN; | 14 | Jakubowska, A; | 15 | Godwin, AK; | ||
| 16 | Arason, A; | 17 | Bane, A; | 18 | Simard, J; | ||
| 19 | Soucy, P; | 20 | Caligo, MA; | 21 | Mai, PL; | ||
| 22 | Claes, KBM; | 23 | Teixeira, MR; | 24 | Chung, WK; | ||
| 25 | Lazaro, C; | 26 | Hulick, PJ; | 27 | Toland, AE; | ||
| 28 | Pedersen, IS; | 29 | Mourits, MJE; | 30 | Neuhausen, SL; | ||
| 31 | Vega, A; | 32 | la Hoya, M; | 33 | Nevanlinna, H; | ||
| 34 | Dhawan, M; | 35 | Zampiga, V; | 36 | Danesi, R; | ||
| 37 | Varesco, L; | 38 | Gismondi, V; | 39 | Vellone, VG; | ||
| 40 | James, PA; | 41 | Janavicius, R; | 42 | Nikitina Zake, L; | ||
| 43 | Nielsen, FC; | 44 | van Overeem Hansen, T; | 45 | Pejovic, T; | ||
| 46 | Borg, A; | 47 | Rantala, J; | 48 | Offit, K; | ||
| 49 | Montagna, M; | 50 | Nathanson, KL; | 51 | Domchek, SM; | ||
| 52 | Osorio, A; | 53 | García, MJ; | 54 | Karlan, BY; | ||
| 55 | Lesueur, F; | 56 | De Fazio, A; | 57 | Bowtell, D; | ||
| 58 | De Fazio, A; | 59 | McGuffog, L; | 60 | Leslie, G; | ||
| 61 | Parsons, MT; | 62 | Dörk, T; | 63 | Speith, LM; | ||
| 64 | dos Santos, ES; | 65 | da Costa, AABA; | 66 | Radice, P; | ||
| 67 | Peterlongo, P; | 68 | Papi, L; | 69 | Engel, C; | ||
| 70 | Hahnen, E; | 71 | Schmutzler, RK; | 72 | Wappenschmidt, B; | ||
| 73 | Easton, DF; | 74 | Tischkowitz, M; | 75 | Singer, CF; | ||
| 76 | Tan, YY; | 77 | Whittemore, AS; | 78 | Sieh, W; | ||
| 79 | Brenton, JD; | 80 | Yannoukakos, D; | 81 | Fostira, F; | ||
| 82 | Konstantopoulou, I; | 83 | Soukupova, J; | 84 | Vocka, M; | ||
| 85 | Chenevix Trench, G; | 86 | Pharoah, PDP; | 87 | Antoniou, AC; | ||
| 88 | Goldgar, DE; | 89 | Spurdle, AB; | 90 | Michailidou, K; | ||
| 91 | la Hoya, M; | 92 | van Overeem Hansen, T; | 93 | dos Santos, ES; | ||
| 94 | HEBON Investigators; | 95 | GEMO Study Collaborators; | 96 | AOCS Group; | ||
| 97 | CZECANCA Consortium; | 98 | The Consortium of Investigators of Modifiers of BRCA1/2; | 99 | Evidence based Network for the Interpretation of Germline Mutant Alleles Consortium; |
